Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

1.608 +0.028 (+1.80%)

Streaming Delayed Price Updated: 2:22 PM EST, Feb 13, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	258,287
Open	1.580
Bid (Size)	1.600 (18,100)
Ask (Size)	1.610 (10,100)
Prev. Close	1.580
Today's Range	1.570 - 1.625
52wk Range	1.300 - 2.979
Shares Outstanding	210,356,896
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Law Offices of Howard G. Smith Encourages Inovio Pharmaceuticals, Inc. (INO) Shareholders To Inquire About Securities Fraud Class Action

Today 12:29 EST

From Law Offices of Howard G. Smith

Via Business Wire

Securities Fraud Investigation Into Inovio Pharmaceuticals, Inc. (INO) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

February 12, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Performance

YTD	-4.8%	-4.8%
1 Month	+0.5%	+0.5%
3 Month	-17.5%	-17.5%
6 Month	-0.7%	-0.7%
1 Year	-24.5%	-24.5%

More News

Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

February 12, 2026

From Law Offices of Howard G. Smith

Via Business Wire

Earnings Scheduled For November 10, 2025 ↗

November 10, 2025

Via Benzinga

Earnings Outlook For Inovio Pharmaceuticals ↗

August 11, 2025

Via Benzinga

Securities Fraud Investigation Into Inovio Pharmaceuticals, Inc. (INO) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

February 12, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – INO

February 12, 2026

From DJS Law Group

Via Business Wire

INOVIO CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

February 11, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

February 11, 2026

From The Schall Law Firm

Via Business Wire

Rosen Law Firm Urges Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Stockholders to Contact the Firm for Information About Their Rights

February 09, 2026

From Rosen Law Firm

Via Business Wire

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Inovio Pharmaceuticals, Inc. Class Action Lawsuit

February 09, 2026

From Robbins LLP

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO

February 03, 2026

From Pomerantz LLP

Via GlobeNewswire

*CORRECTION*INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO

January 20, 2026

From Pomerantz LLP

Via GlobeNewswire

*CORRECTION*INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO

January 13, 2026

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO

January 06, 2026

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO

December 30, 2025

From Pomerantz LLP

Via GlobeNewswire

Biopharma’s Year-End Rollercoaster: Mereo Plummets 90% as BioMarin Seals $4.8 Billion Amicus Deal

December 29, 2025

Via MarketMinute

Gapping stocks in Friday's session ↗

August 15, 2025

Via Chartmill

Inovio Cuts Q2 Losses by 27% ↗

August 13, 2025

Via The Motley Fool

INOVIO PHARMACEUTICALS INC (NASDAQ:INO) Reports Q2 2025 Results: Revenue at $0.0, EPS Loss of $0.61 Amid 4.7% After-Hours Drop ↗

August 12, 2025

Via Chartmill

This Wingstop Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

July 09, 2025

Via Benzinga

Earnings Scheduled For August 12, 2025 ↗

August 12, 2025

Via Benzinga

Which stocks are moving after the closing bell on Friday? ↗

July 04, 2025

Via Chartmill

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 03, 2025

Via Benzinga

Top movers in Thursday's after hours session ↗

July 03, 2025

Via Chartmill

Frequently Asked Questions

Is Inovio Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Inovio Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Inovio Pharmaceuticals, Inc. - Common Stock trade on?

Inovio Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Inovio Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Inovio Pharmaceuticals, Inc. - Common Stock is INO on the Nasdaq Stock Market

What is the current price of Inovio Pharmaceuticals, Inc. - Common Stock?

The current price of Inovio Pharmaceuticals, Inc. - Common Stock is 1.608

When was Inovio Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Inovio Pharmaceuticals, Inc. - Common Stock was at 02/13/26 02:22 PM ET

What is the market capitalization of Inovio Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Inovio Pharmaceuticals, Inc. - Common Stock is 338.34M

How many shares of Inovio Pharmaceuticals, Inc. - Common Stock are outstanding?

Inovio Pharmaceuticals, Inc. - Common Stock has 338M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.